{
  "id": 20319035,
  "title": "Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head",
  "url": "https://urgent.news/2026/11/16/where-will-eli-lilly-be-in-10-years-1-clue-its-next-potential-20319035",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-11-16T19:23:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/where-will-eli-lilly-be-10-years-1-clue-its-next-potential-blockbuster-just-beat-ozempic"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsRetatrutide beat Ozempic in a head-to-head trial, highlighting Lilly’s dominance in its core area.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head",
        "url": "https://urgent.news/2026/11/16/where-will-eli-lilly-be-in-10-years-1-clue-its-next-potential",
        "published": "2026-11-16T19:03:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}